Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N9PL
|
|||
| Former ID |
DCL001134
|
|||
| Drug Name |
ACE-041
|
|||
| Synonyms |
N-(5-bromo-2-methylpyridin-4-yl)acetamide; 1244949-22-1; ACE041; DTXSID10670359; 4605AA; ZINC38540942; AKOS016011880; FCH1349294; AJ-96556; EN001564; KB-258244; AX8247344; Acetamide, N-(5-bromo-2-methyl-4-pyridinyl)-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Age-related macular degeneration [ICD-11: 9B75.0; ICD-10: H35] | Phase 1 | [1] | |
| Company |
Acceleron Pharma
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H9BrN2O
|
|||
| Canonical SMILES |
CC1=CC(=C(C=N1)Br)NC(=O)C
|
|||
| InChI |
1S/C8H9BrN2O/c1-5-3-8(11-6(2)12)7(9)4-10-5/h3-4H,1-2H3,(H,10,11,12)
|
|||
| InChIKey |
OMGSODSTISOTIL-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1244949-22-1
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Growth/differentiation factor 2 (GDF2) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Acceleron Pharma (2011). | |||
| REF 2 | Company report (Acceleron Pharma) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.